← Back
$ADPT All transactions

Adaptive Biotechnologies Corp

M 10b5-1 Plan

$ Value

$286K

Shares

36,650

Price

$8

Filed

Jan 14

Insider

Name

LO FRANCIS

Title

Chief People Officer

CIK

0001780660

Roles

Officer

Transaction Details

Transaction Date

2026-01-12

Code

M

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

352,628

Footnotes

The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2025. | The option is fully vested and exercisable. | The options vested with respect to 1/4 of such shares on March 4, 2023, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested. | The options vested with respect to 1/4 of such shares on March 4, 2024, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested. | The options vested with respect to 1/4 of such shares on March 4, 2025, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.

Filing Info

Accession No.

0001780660-26-000003

Form Type

4

Issuer CIK

0001478320

LO FRANCIS's History

Date Ticker Type Value
2026-04-08 ADPT M $9K
2026-04-08 ADPT $340K
2026-04-08 ADPT M $0
2026-03-11 ADPT $431K
2026-03-05 ADPT $575K
2026-03-04 ADPT A $0
2026-01-12 ADPT M $286K
2026-01-12 ADPT M $94K
2026-01-12 ADPT M $178K
2026-01-12 ADPT M $57K

Other Insiders at ADPT (90d)

Insider Bought Sold Last
GRIFFIN MICHELLE RENEE $949K 2026-03-11
NEUPERT PETER M 2026-03-04
HERSHBERG ROBERT 2026-03-04
ROBINS CHAD M
CEO and Chairman
$18.6M 2026-04-08
LO FRANCIS
Chief People Officer
$1.3M 2026-04-08
PISKEL KYLE
Chief Financial Officer
$286K 2026-03-11
RUBINSTEIN JULIE
President and COO
$11.5M 2026-04-21
ROBINS HARLAN S
Chief Scientific Officer
$7.5M 2026-04-08
BENZENO SHARON
Chief Commercial Ofc Imm Med
$831K 2026-03-11
BOBULSKY SUSAN
Chief Commercial Officer, MRD
$544K 2026-03-11
OWEN KATEY EINTERZ 2026-03-04